![]() |
市场调查报告书
商品编码
1500381
Holter心电图监测仪市场:按产品类型、导极类型和最终用户划分 - 全球预测 2024-2030 年Holter ECG Market by Product (Software, Wired Holter ECG Monitors, Wireless Holter ECG Monitors), Lead Type (12-Lead, 3-Lead, 6-Lead), End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
Holter心电图监测仪市场规模预计 2023 年为 4.4699 亿美元,预计 2024 年将达到 4.7265 亿美元,2030 年将达到 6.7603 亿美元,复合年增长率为 6.08%。
Holter心电图监测仪是医生用来诊断和监测心律不整患者的医疗设备。这些设备连续记录 24 至 48 小时的心电图 (ECG) 讯号,以检测需要进一步调查或治疗的异常心率或心律不整。心血管疾病 (CVD) 的流行、心律不整风险增加的人口老化、远端心臟监测技术的进步以及人们对早期诊断和预防保健措施的认识不断提高,使得Holter心电图监测仪 的正确诊断和治疗方法变得更加重要。然而,Holter心电图监测仪设备的高成本对小型医疗机构造成了财务障碍。用于远端患者监护的远距远端医疗服务的快速采用也为Holter心电图监测仪製造商创造了新的机会,以扩大其产品在全球的覆盖范围。
主要市场统计 | |
---|---|
基准年[2023] | 44699万美元 |
预测年份 [2024] | 47265万美元 |
预测年份 [2030] | 67603万美元 |
复合年增长率(%) | 6.08% |
区域洞察
Holter心电图监测仪市场正在美洲发展,由于人口老化和心臟病发病率增加,人们对心臟健康的兴趣日益增加。我们致力于透过研究和技术投资来改善心臟护理,从而提高美洲的诊断能力。在欧盟 (EU),医疗保健提供者正在采用Holter心电图监测仪等先进技术,透过早期检测心臟疾病来改善患者的治疗结果。在 EMEA(欧洲、中东和非洲)地区,随着各国政府专注于发展医疗保健基础设施和促进医疗旅游,对先进医疗保健服务的需求正在快速增长。非洲人民越来越意识到预防心臟病的措施,增加了对包括心臟心电图在内的诊断解决方案的需求。亚太地区专注于医疗设备的研究和开发,政府计划和计划强调心臟病早期诊断和干预的重要性,导致我们在该地区的医疗机构中引入Holter心电图监测仪。此外,技术进步和最尖端科技的整合预计将提高精度和准确度,加速全球最终用户对Holter心电图监测仪的使用。
FPNV定位矩阵
FPNV 定位矩阵对于评估Holter心电图监测仪市场供应商的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对Holter心电图监测仪市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该领域竞争性质的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在Holter心电图监测仪市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[195 Pages Report] The Holter ECG Market size was estimated at USD 446.99 million in 2023 and expected to reach USD 472.65 million in 2024, at a CAGR 6.08% to reach USD 676.03 million by 2030.
Holter ECG is a medical device that enables physicians to diagnose and monitor patients with heart rhythm disorders. These devices continuously record electrocardiogram (ECG) signals for 24 to 48 hours to detect abnormal heartbeats or arrhythmias requiring further investigation and treatment. Prevalence of cardiovascular diseases (CVDs), increasing aging population with increased risk of arrhythmias, technological advancements in remote cardiac monitoring, and growing awareness regarding early diagnosis and preventive healthcare measures are raising the need for efficient medical devices, including holter ECG, for appropriate diagnosis and treatment. However, the high cost of Holter ECG devices can be a financial barrier for small-scale healthcare facilities. The surge in the adoption of telemedicine services in remote patient monitoring has also created new opportunities for Holter ECG manufacturers to expand their product reach worldwide.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 446.99 million |
Estimated Year [2024] | USD 472.65 million |
Forecast Year [2030] | USD 676.03 million |
CAGR (%) | 6.08% |
Regional Insights
The Holter ECG market is evolving in the Americas owing to the growing focus on cardiac health due to an aging population and increasing incidences of heart disease. Emphasis on improving cardiac care through investments in research and technology enhances diagnostic capabilities in the Americas. In the European Union, healthcare providers are adopting advanced technologies such as Holter ECG to improve patient outcomes by early detection of heart diseases. The EMEA region has experienced rapid growth in demand for advanced healthcare services with a focus on governments on healthcare infrastructure development and promoting medical tourism. There has been an increasing focus on creating awareness about preventive measures for cardiac conditions among the African population, raising the need for diagnostic solutions, including heart ECG. The APAC region is focusing on medical device research and development coupled with government schemes and programs emphasizing the importance of early diagnosis and intervention for cardiac conditions, which are expanding the deployment of Holter ECG in the healthcare facilities in the region. Besides, the technological advancements and integration of cutting-edge technologies are anticipated to enhance accuracy and precision, thereby accelerating the use of Holter ECG by end-users across the globe.
Market Insights
The market dynamics represent an ever-changing landscape of the Holter ECG Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Holter ECG Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Holter ECG Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
UltraLinQ to launch new cardiac monitoring product at Arab Health
Ultralinq announced the launch of ITS latest product in cardiac monitoring at Arab Health 2021. This innovative solution offers advanced and comprehensive Holter ECG monitoring for improved patient care. The state-of-the-art Holter ECG monitor can record and store up to 14 days of high-quality ECG data. Its user-friendly design simplifies the patient experience and reduces the time spent during clinic appointments. [Published On: 2023-01-13]
Xplore Lifestyle to launch CardiacSense, world's first medical grade watch to monitor the heart
Xplore Lifestyle introduced CardiacSense, the medical-grade watch for monitoring heart health. The device can record continuous Holter ECG (Electrocardiogram) for up to 48 hours. With this watch, users can track their heart rate and identify even minor irregularities in heart rhythms. Furthermore, it provides real-time monitoring of cardiovascular disease, arrhythmias, and other detected abnormalities in the heart. [Published On: 2022-07-27]
Three-lead Holter monitor for low-risk patients gains FDA 510(k) clearance
The FDA cleared a three-lead Holter monitor device by Biotricity for use in low-risk patients. This compact and lightweight Holter monitoring device is designed to provide high-precision ECG recordings, enabling effective diagnosis and treatment decisions. The clearance from the FDA affirms the device's safety and reliability, making it a trusted monitoring option in the United States. [Published On: 2022-01-25]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Holter ECG Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Holter ECG Market, highlighting leading vendors and their innovative profiles. These include AlivCor Inc., Bardy Diagnostics, Inc., BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED, Cardiac Insight, Inc., custo med GmbH, EB Neuro S.p.A., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom Holdings, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., LifeSignals Group Inc., Medtronic plc, Nasiff Associates, Inc., Nihon Kohden Corporation, Nissha Co. Ltd., OSI Systems, Inc., SCHILLER AG, Viatom Technology Co. Ltd., and VitalConnect.
Market Segmentation & Coverage